Testosterone/dutasteride
| Combination of | |
|---|---|
| Testosterone | Androgen |
| Dutasteride | 5α-Reductase inhibitor |
| Clinical data | |
| Other names | Dutasteride/testosterone |
Testosterone/dutasteride is a combination formulation of testosterone, an androgen, and dutasteride, a 5α-reductase inhibitor, which was under development by GlaxoSmithKline for the treatment of hypogonadism (low testosterone levels) in men in the 2000s.[1] It reached phase II clinical trials prior to the discontinuation of its development.[1]
References
- ^ a b "Testosterone/dutasteride". AdisInsight. Springer Nature Switzerland AG.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.